As of January 2025, Newron Pharmaceuticals has a market cap of $168.27M. This makes Newron Pharmaceuticals the world's 17253th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $164.90M | 68.08% |
2023 | $98.11M | 219.35% |
2022 | $30.72M | -4.32% |
2021 | $32.11M | -24.65% |
2020 | $42.61M | -66.14% |
2019 | $125.85M | 13.19% |
2018 | $111.19M | -51.64% |
2017 | $229.90M | -42.43% |
2016 | $399.36M | -21.29% |
2015 | $507.37M | -2.29% |
2014 | $519.27M | 55.95% |
2013 | $332.96M | 108.96% |
2012 | $159.35M | 265.45% |
2011 | $43.60M | -61.27% |
2010 | $112.57M | -69.63% |
2009 | $370.62M | 34.53% |
2008 | $275.49M | -72.75% |
2007 | $1.01B | -4.32% |
2006 | $1.06B | - |